Literature DB >> 19800842

Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: a 3-yr prospective study.

Lucila Cassino1, Natalia Laufer, Horacio Salomon, Rodolfo Campos, Jorge Quarleri.   

Abstract

BACKGROUND: The course of chronic HBV infection is modified by HIV-coexistence.
OBJECTIVE: To analyze the role of HBV genomic heterogeneity in basal core promoter (BCP) and precore (Pc) genomic regions. STUDY
DESIGN: In a 3-yr prospective study, 39 HBV infected patients (20 monoinfected and 19 HIV-coinfected) were included. Eighty-two HBV isolates were studied at quasispecies level in the BCP/Pc genomic region. Clinical records obtained include data on lamivudine therapy and resistance mutations, HBV and HIV-viral load.
RESULTS: HBV isolates were predominantly ascribed to genotype (Gt) A2 among HBV-monoinfected and HIV-coinfected patients. BCP mutations in isolates from monoinfected patients were significantly more frequent than in those from coinfected ones, irrespective of the HBe expression pattern (p<0.0001). Regardless of the HIV-coexistence, the Pc mutation at G1896A only barely appeared among clone-derived sequences of GtF1 isolates, mainly from HBe(-) HBV-monoinfected patients.
CONCLUSIONS: HBV isolates characterized from HIV-coinfected patients seem to be more prone to exhibit a wild type genomic pattern at BCP regulatory region with respect to those from HBV-monoinfected ones. Besides, mutations at Pc region might be genotype-dependent in their frequency but not on HIV co-presence related.

Entities:  

Mesh:

Year:  2009        PMID: 19800842     DOI: 10.1016/j.jcv.2009.09.015

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  9 in total

1.  Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.

Authors:  Jennifer Grant; Oche Agbaji; Anna Kramvis; Mukhlid Yousif; Mu'azu Auwal; Sudhir Penugonda; Placid Ugoagwu; Robert Murphy; Claudia Hawkins
Journal:  Trop Med Int Health       Date:  2017-05-22       Impact factor: 2.622

2.  Comparison and Correlation of Genetic Variability of the HBV Pre-S Region in HIV/HBV Co-Infected Patients: Quasispecies Perspective.

Authors:  Yuan Nie; Xizi Deng; Yun Lan; Linghua Li; Feng Li; Fengyu Hu
Journal:  Infect Drug Resist       Date:  2020-12-01       Impact factor: 4.003

Review 3.  Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.

Authors:  Zhuo-Lun Song; Yu-Jun Cui; Wei-Ping Zheng; Da-Hong Teng; Hong Zheng
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

4.  Drug-resistant and immune-escape hepatitis B virus mutants, occult hepatitis B infection and coinfections in public hospital patients from Argentina.

Authors:  Cecilia María Delfino; Marianela Giorgio; Gabriela García; Silvia Sánchez Puch; Estela Outon; Verónica Lidia Mathet
Journal:  Virus Genes       Date:  2021-06-06       Impact factor: 2.332

5.  High prevalence of the B2+C2 subgenotype mixture in patients with chronic hepatitis B in Eastern China.

Authors:  Jun Zhong; Yue-Qiu Gao; Xue-Hua Sun; Xiao-Jun Zhu; Man Li
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

6.  Convergence and coevolution of hepatitis B virus drug resistance.

Authors:  Hong Thai; David S Campo; James Lara; Zoya Dimitrova; Sumathi Ramachandran; Guoliang Xia; Lilia Ganova-Raeva; Chong-Gee Teo; Anna Lok; Yury Khudyakov
Journal:  Nat Commun       Date:  2012-04-17       Impact factor: 14.919

7.  Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations.

Authors:  Lucila Cassino; Silvina Benetti; Fabian Fay; Hugo Tanno; Jorge Quarleri
Journal:  BMC Infect Dis       Date:  2011-06-22       Impact factor: 3.090

8.  Evaluation of intra-host variants of the entire hepatitis B virus genome.

Authors:  Sumathi Ramachandran; Xiangjun Zhai; Hong Thai; Davis S Campo; Guoliang Xia; Lilia M Ganova-Raeva; Jan Drobeniuc; Yury E Khudyakov
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

9.  Pre-S Deletions are Predominant Quasispecies in HIV/HBV Infection: Quasispecies Perspective.

Authors:  Yuan Nie; Xi-Zi Deng; Yun Lan; Feng Li; Feng-Yu Hu
Journal:  Infect Drug Resist       Date:  2020-06-08       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.